Applying Recombinant Antibody Engineering to Further Immunoassay Development

Antibody engineering and recombinant expression continue to grow in the diagnostics industry, and for good reasons. Recombinant antibody technology allows you to obtain highly reliable antibodies tailored to your specific assay, enabling superior performance for the entire lifespan of a diagnostic. This webinar will focus on how antibody engineering allows assay developers to custom design antibodies to improve their performance in rapid diagnostic tests. Topics will include: 

• Generating precisely defined controls in unique formats, including IgG, IgA and IgM, for serology rapid tests in the infectious disease field 
• Streamlining immobilization and conjugation chemistries with standardized Fc domains  

• Creating non-natural antibody scaffolds for higher avidity detection and capture 
• Leveraging other novel antibody formats, including chimeric antibodies, fragments and bispecifics 

Join us on Thursday October 5th 11am EST|5pm CEST for the live webinar 

Register here!   

Speaker: Alex Scott – Business Development Manager Europe 

Alex Scott joined the Absolute Biotech team in 2022 as the Business Development Manager for Europe. His previous experience includes scientific roles in medicinal chemistry and drug discovery. Alex possesses a Master’s Degree in Chemistry from the University of Bath.  

Absolute Antibody is now part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Our mission is to serve as “antibody curators” for customers worldwide, treating each antibody like a work of art to deliver unique and absolutely defined reagents that empower scientists.